Skip to main content

Vitamin D and risk of CVD: a review of the evidence

  • Catherine M. Fry (a1) and Thomas A. B. Sanders (a1)

This review summarises evidence for an association between vitamin D status and CVD and the mechanisms involved. Vitamin D3 is predominantly provided by the action of UVB from sunlight on skin. Average UK diets supply 2–3 μg/d vitamin D but diets containing at least one portion of oily fish per week supply about 7 μg/d. Pharmacological doses of vitamin D2 (bolus injection of 7500 μg or intakes >50 μg/d) result in a smaller increase in plasma 25(OH)D than those of D3 but physiological doses 5–25 μg/d seem equivalent. Plasma 25(OH)D concentrations are also influenced by clothing, obesity and skin pigmentation. Up to 40 % of the population have plasma 25(OH)D concentrations <25 nmol/l in the winter compared with <10 % in the summer. The relative risk of CVD death is 1·41 (95 % CI 1·18, 1·68) greater in the lowest quintile of plasma 25(OH)D according to meta-analysis of prospective cohort studies. Acute deficiency may inhibit insulin secretion and promote inflammation thus increasing the risk of plaque rupture and arterial thrombosis. Chronic insufficiency may increase arterial stiffness. There is no evidence to support claims of reduced CVD from existing trials with bone-related health outcomes where vitamin D was usually co-administered with calcium. Although several trials with cardiovascular endpoints are in progress, these are using pharmacological doses. In view of the potential toxicity of pharmacological doses, there remains a need for long-term trials of physiological doses of D2 and D3 with CVD incidence as the primary outcome.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Vitamin D and risk of CVD: a review of the evidence
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Vitamin D and risk of CVD: a review of the evidence
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Vitamin D and risk of CVD: a review of the evidence
      Available formats
Corresponding author
* Corresponding author: C. Fry, email
Hide All
1. Norman, AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88, 491S499S.
2. Binkley, N, Krueger, D, Cowgill, CS et al. (2004) Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 89, 31523157.
3. Phinney, KW (2008) Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 88, 511S512S.
4. DEQAS (2014) Vitamin D External Quality Assessment Scheme. (accessed October 2014).
5. Chun, RF, Peercy, BE, Orwoll, ES et al. (2013) Vitamin D and Dbp: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 144, 132137.
6. Glendenning, P, Chew, GT, Inderjeeth, CA et al. (2013) Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone 56, 271275.
7. Bikle, DD & Gee, E (1989) Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 124, 649654.
8. Safadi, FF, Thornton, P, Magiera, H et al. (1999) Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 103, 239251.
9. Powe, CE, Evans, MK, Wenger, J et al. (2013) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369, 19912000.
10. Powe, CE, Ricciardi, C, Berg, AH et al. (2011) Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 26, 16091616.
11. Anderson, JL, May, HT, Horne, BD et al. (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106, 963968.
12. Kendrick, J, Targher, G, Smits, G et al. (2009) 25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis 205, 255260.
13. Zehnder, D, Bland, R, Chana, RS et al. (2002) Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 13, 621629.
14. Hewison, M, Burke, F, Evans, KN et al. (2007) Extra-renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103, 316321.
15. Rahman, A, Hershey, S, Ahmed, S et al. (2007) Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 103, 416419.
16. Merke, J, Milde, P, Lewicka, S et al. (1989) Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 83, 19031915.
17. Ashwell, M, Stone, EM, Stolte, H et al. (2010) UK food standards agency workshop report: an investigation of the relative contributions of diet and sunlight to vitamin D status. Br J Nutr 104, 603611.
18. Clemens, TL, Adams, JS, Henderson, SL et al. (1982) Increased skin pigment reduces the capacity of skin to synthesise vitamin D3 . Lancet 1, 7476.
19. Solanki, T, Hyatt, RH, Kemm, JR et al. (1995) Are elderly Asians in Britain at a high risk of vitamin D deficiency and osteomalacia? Age Ageing 24, 103107.
20. Holick, MF, Binkley, NC, Bischoff-Ferrari, HA et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96, 19111930.
21. MacLaughlin, J & Holick, MF (1985) Aging decreases the capacity of human skin to produce vitamin D3 . J Clin Invest 76, 15361538.
22. Pearce, SH & Cheetham, TD (2010) Diagnosis and management of vitamin D deficiency. BMJ 340, b5664.
23. Bates, B, Lennox, A, Prentice, A et al. (2014) National Diet and Nutrition Survey. Results from Years 1, 2, 3 and 4 (Combined) of the Rolling Programme (2008/2009–2011/2012). London: Public Health England.
24. SACN (2007) Scientific Advisory Committee on Nutrition – Update on Vitamin D. London: TSO.
25. Chen, PS Jr & Bosmann, HB (1964) Effect of vitamins D2 and D3 on serum calcium and phosphorus in rachitic chicks. J Nutr 83, 133139.
26. Hunt, RD, Garcia, FG & Walsh, RJ (1972) A comparison of the toxicity of ergocalciferol and cholecalciferol in Rhesus monkeys (Macaca mulatta). J Nutr 102, 975986.
27. Gordon, CM, Williams, AL, Feldman, HA et al. (2008) Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab 93, 27162721.
28. Medicines Commission (1980) British Pharmacopoeia. London: Her Majesty's Stationery Office.
29. Committee of Revision (1997) Drug Information for the Health Care Professional, 17th ed. Rockville, MD, USA: Pharmacopoeial Convention.
30. Houghton, LA & Vieth, R (2006) The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 84, 694697.
31. Tripkovic, L, Lambert, H, Hart, K et al. (2012) Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95, 13571364.
32. Binkley, N, Gemar, D, Engelke, J et al. (2011) Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 Iu daily or 50,000 Iu monthly in older adults. J Clin Endocrinol Metab 96, 981988.
33. Armas, LAG, Hollis, BW & Heaney, RP (2004) Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89, 53875391.
34. Romagnoli, E, Mascia, ML, Cipriani, C et al. (2008) Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 93, 30153020.
35. Trang, HM, Cole, DE, Rubin, LA et al. (1998) Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2 . Am J Clin Nutr 68, 854858.
36. Heaney, RP, Recker, RR, Grote, J et al. (2011) Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 96, E447E452.
37. Leventis, P & Kiely, PD (2009) The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 38, 149153.
38. Fisk, CM, Theobald, HE & Sanders, TA (2012) Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to Uv-B. J Nutr 142, 12861290.
39. Biancuzzo, RM, Young, A, Bibuld, D et al. (2010) Fortification of orange juice with vitamin D2 or vitamin D3 is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr 91, 16211626.
40. Holick, MF, Biancuzzo, RM, Chen, TC et al. (2008) Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93, 677681.
41. Wortsman, J, Matsuoka, LY, Chen, TC et al. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690693.
42. Waldron, JL, Ashby, HL, Cornes, MP et al. (2013) Vitamin D: a negative acute phase reactant. J Clin Pathol 66, 620622.
43. Hunter, D, De Lange, M, Snieder, H et al. (2001) Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 16, 371378.
44. Fu, L, Yun, F, Oczak, M et al. (2009) Common genetic variants of the vitamin D binding protein (Dbp) predict differences in response of serum 25-hydroxyvitamin D [25(Oh)D] to vitamin D supplementation. Clin Biochem 42, 11741177.
45. Schottker, B, Jorde, R, Peasey, A et al. (2014) Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 348, g3656.
46. Theodoratou, E, Tzoulaki, I, Zgaga, L et al. (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348, g2035.
47. Li, YC (2003) Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 88, 327331.
48. Li, YC, Qiao, G, Uskokovic, M et al. (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89–90, 387392.
49. Fitzpatrick, LA, Bilezikian, JP & Silverberg, SJ (2008) Parathyroid hormone and the cardiovascular system. Curr Osteoporos Rep 6, 7783.
50. Snijder, MB, Lips, P, Seidell, JC et al. (2007) Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 261, 558565.
51. Hulter, HN, Melby, JC, Peterson, JC et al. (1986) Chronic continuous Pth infusion results in hypertension in normal subjects. J Clin Hypertens 2, 360370.
52. Carthy, EP, Yamashita, W, Hsu, A et al. (1989) 1,25-dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 13, 954959.
53. Bonetti, PO, Lerman, LO & Lerman, A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23, 168175.
54. Griendling, KK & FitzGerald, GA (2003) Oxidative stress and cardiovascular injury part I: basic mechanisms and in vivo monitoring of Ros. Circulation 108, 19121916.
55. Molinari, C, Uberti, F, Grossini, E et al. (2011) 1alpha,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 27, 661668.
56. Andrukhova, O, Slavic, S, Zeitz, U et al. (2014) Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol 28, 5364.
57. Arnett, DK, Evans, GW & Riley, WA (1994) Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 140, 669682.
58. Wagenseil, JE & Mecham, RP (2012) Elastin in large artery stiffness and hypertension. J Cardiovasc Transl Res 5, 264273.
59. Coussens, A, Timms, PM, Boucher, BJ et al. (2009) 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by mycobacterium tuberculosis infection. Immunology 127, 539548.
60. Anand, SP & Selvaraj, P (2009) Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases Mmp-7, Mmp-9 and the inhibitor Timp-1 in pulmonary tuberculosis. Clin Immunol 133, 126131.
61. Watson, KE, Abrolat, ML, Malone, LL et al. (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96, 17551760.
62. Basalyga, DM, Simionescu, DT, Xiong, W et al. (2004) Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 110, 34803487.
63. Chen, S, Law, CS & Gardner, DG (2010) Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of Cdk2 activity. J Steroid Biochem Mol Biol 118, 135141.
64. Zieman, SJ, Melenovsky, V & Kass, DA (2005) Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25, 932943.
65. Muller, K, Haahr, PM, Diamant, M et al. (1992) 1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4, 506512.
66. Cohen-Lahav, M, Douvdevani, A, Chaimovitz, C et al. (2007) The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 103, 558562.
67. Matilainen, JM, Husso, T, Toropainen, S et al. (2010) Primary effect of 1alpha,25(Oh)(2)D(3) on Il-10 expression in monocytes is short-term down-regulation. Biochim Biophys Acta 1803, 12761286.
68. Song, Y, Hong, J, Liu, D et al. (2013) 1,25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor Ikappabalpha Via Mrna stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells. Scand J Immunol 77, 109116.
69. Zittermann, A, Schleithoff, SS & Koerfer, R (2007) Vitamin D and vascular calcification. Curr Opin Lipidol 18, 4146.
70. Bland, R, Markovic, D, Hills, CE et al. (2004) Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89–90, 121125.
71. Teegarden, D & Donkin, SS (2009) Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 22, 8292.
72. Pittas, AG, Lau, J, Hu, FB et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 20172029.
73. Burgaz, A, Orsini, N, Larsson, SC et al. (2011) Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 29, 636645.
74. Asemi, Z, Samimi, M, Tabassi, Z et al. (2013) Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J Nutr 143, 14321438.
75. Forman, JP, Scott, JB, Ng, K et al. (2013) Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61, 779785.
76. Jorde, R, Sneve, M, Torjesen, P et al. (2010) No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 267, 462472.
77. Muldowney, S, Lucey, AJ, Hill, TR et al. (2012) Incremental cholecalciferol supplementation up to 15 Mug/D throughout winter at 51–55 degrees N has no effect on biomarkers of cardiovascular risk in healthy young and older adults. J Nutr 142, 15191525.
78. Nagpal, J, Pande, JN & Bhartia, A (2009) A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diab Med 26, 1927.
79. Witham, MD, Dove, FJ, Dryburgh, M et al. (2010) The effect of different doses of vitamin D-3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53, 21122119.
80. Wood, AD, Secombes, KR, Thies, F et al. (2012) Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled Rct. J Clin Endocrinol Metab 97, 35573568.
81. Kunutsor, SK, Burgess, S, Munroe, PB et al. (2014) Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol 29, 114.
82. Mancia, G, De Backer, G, Dominiczak, A et al. (2007) 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (Esh) and of the European Society of Cardiology (Esc). Eur Heart J 28, 14621536.
83. Staessen, JA, Thijs, L, Fagard, R et al. (1999) Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA 282, 539546.
84. Coats, AJ, Radaelli, A, Clark, SJ et al. (1992) The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 10, 385391.
85. Mancia, G, Omboni, S, Parati, G et al. (1995) Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 8, 311315.
86. Larsen, T, Mose, FH, Bech, JN et al. (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25, 12151222.
87. Witham, MD, Dove, FJ, Sugden, JA et al. (2012) The effect of vitamin D replacement on markers of vascular health in stroke patients – a randomised controlled trial. Nutr Metab Cardiovasc Dis 22, 864870.
88. Witham, MD, Price, RJ, Struthers, AD et al. (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the vitdish randomized controlled trial. JAMA Intern Med 173, 16721679.
89. Witham, MD, Ireland, S, Houston, JG et al. (2014) Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension 63, 706712.
90. Yeboah, J, Crouse, JR, Hsu, FC et al. (2007) Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study. Circulation 115, 23902397.
91. Al Mheid, I, Patel, R, Murrow, J et al. (2011) Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58, 186192.
92. Jablonski, KL, Chonchol, M, Pierce, GL et al. (2011) 25-hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57, 6369.
93. Tarcin, O, Yavuz, DG, Ozben, B et al. (2009) Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94, 40234030.
94. Harris, RA, Pedersen-White, J, Guo, DH et al. (2011) Vitamin D(3) supplementation for 16 weeks improves flow-mediated dilation in overweight African–American adults. Am J Hypertens 24, 557562.
95. Sugden, JA, Davies, JI, Witham, MD et al. (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25, 320325.
96. Witham, MD, Adams, F, Kabir, G et al. (2013) Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK – a randomised controlled trial. Atherosclerosis 230, 293299.
97. Yiu, YF, Yiu, KH, Siu, CW et al. (2013) Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227, 140146.
98. Gepner, AD, Ramamurthy, R, Krueger, DC et al. (2012) A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS ONE 7, e36617.
99. Mattace-Raso, FU, van der Cammen, TJ, Hofman, A et al. (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 113, 657663.
100. Terai, M, Ohishi, M, Ito, N et al. (2008) Comparison of arterial functional evaluations as a predictor of cardiovascular events in hypertensive patients: the Non-Invasive Atherosclerotic Evaluation in Hypertension (Noah) study. Hypertens Res 31, 11351145.
101. Mayer, O Jr, Filipovsky, J, Seidlerova, J et al. (2012) The association between low 25-hydroxyvitamin D and increased aortic stiffness. J Hum Hypertens 26, 650655.
102. Kuloglu, O, Gur, M, Seker, T et al. (2013) Serum 25-hydroxyvitamin D level is associated with arterial stiffness, left ventricle hypertrophy, and inflammation in newly diagnosed hypertension. J Investig Med 61, 989994.
103. Giallauria, F, Milaneschi, Y, Tanaka, T et al. (2012) Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. J Clin Endocrinol Metab 97, 37173723.
104. Pirro, M, Manfredelli, MR, Helou, RS et al. (2012) Association of parathyroid hormone and 25-Oh-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb 19, 924931.
105. Seker, T, Gur, M, Kuloglu, O et al. (2013) Serum 25-hydroxyvitamin D is associated with both arterial and ventricular stiffness in healthy subjects. J Cardiol 62, 361365.
106. Webb, DR, Khunti, K, Lacy, P et al. (2012) Conduit vessel stiffness in British South Asians of Indian descent relates to 25-hydroxyvitamin D status. J Hypertens 30, 15881596.
107. Rezai, MR, Wallace, AM, Sattar, N et al. (2011) Ethnic differences in aortic pulse wave velocity occur in the descending Aorta and may be related to vitamin D. Hypertension 58, 247253.
108. Breslavsky, A, Frand, J, Matas, Z et al. (2013) Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 32, 970975.
109. Benetos, A, Waeber, B, Izzo, J et al. (2002) Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15, 11011108.
110. de Boer, IH, Kestenbaum, B, Shoben, AB et al. (2009) 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 20, 18051812.
111. Torres, JL & Ridker, PM (2003) Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol 18, 471478.
112. Asemi, Z, Hashemi, T, Karamali, M et al. (2013) Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. Am J Clin Nutr 98, 14251432.
113. Belenchia, AM, Tosh, AK, Hillman, LS et al. (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 97, 774781.
114. Jorde, R, Sneve, M, Torjesen, PA et al. (2010) No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 50, 175180.
115. Pittas, AG, Harris, SS, Stark, PC et al. (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diab Care 30, 980986.
116. von Hurst, PR, Stonehouse, W & Coad, J (2010) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br J Nutr 103, 549555.
117. Timms, PM, Mannan, N, Hitman, GA et al. (2002) Circulating Mmp9, vitamin D and variation in the Timp-1 response with Vdr genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95, 787796.
118. Witham, MD, Dove, FJ, Khan, F et al. (2013) Effects of vitamin D supplementation on markers of vascular function after myocardial infarction – a randomised controlled trial. Int J Cardiol 167, 745749.
119. Chen, N, Wan, Z, Han, SF et al. (2014) Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients 6, 22062216.
120. Chiu, KC, Chu, A, Go, VL et al. (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79, 820825.
121. Kayaniyil, S, Vieth, R, Retnakaran, R et al. (2010) Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diab Care 33, 13791381.
122. Liu, E, Meigs, JB, Pittas, AG et al. (2009) Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 139, 329334.
123. Nikooyeh, B, Neyestani, TR, Farvid, M et al. (2011) Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93, 764771.
124. Patel, P, Poretsky, L & Liao, E (2010) Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in type 2 diabetes: a pilot prospective randomized trial. J Diab 2, 3640.
125. George, PS, Pearson, ER & Witham, MD (2012) Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diab Med 29, e142e150.
126. Bjelakovic, G, Gluud, LL, Nikolova, D et al. (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 6, Cd007469.
127. Zheng, Y, Zhu, J, Zhou, M et al. (2013) Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS ONE 8, e82109.
128. Chowdhury, R, Kunutsor, S, Vitezova, A et al. (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903.
129. Bolland, MJ, Grey, A, Gamble, GD et al. (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diab Endocrinol 2, 307320.
130. Bolland, MJ, Grey, A, Avenell, A et al. (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the women's health initiative limited access dataset and meta-analysis. BMJ 342, d2040.
131. Ford, JA, MacLennan, GS, Avenell, A et al. (2014) Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 100, 746755.
132. Matsuoka, LY, Ide, L, Wortsman, J et al. (1987) Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64, 11651168.
133. Fisk, CM, Reidlinger, DP & Sanders, TAB (2013) Advice to consume 1–2 portions of oily fish per week improves vitamin D status. Proc Nutr Soc 72(OCE4), E188.
134. Cashman, KD, Hill, TR, Lucey, AJ et al. (2008) Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 88, 15351542.
135. Cashman, KD, Wallace, JM, Horigan, G et al. (2009) Estimation of the dietary requirement for vitamin D in free-living adults ≥64 y of age. Am J Clin Nutr 89, 13661374.
136. Bassuk, SS & Manson, JE (2009) Does vitamin D protect against cardiovascular disease? J Cardiovasc Transl Res 2, 245250.
137. IOM (1997) Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. WD, USA: National Academy Press.
138. European Commission Health Consumer Protection Directorate-General (2002) Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Vitmain D. Brussels: European Commission.
139. Verhagen, H, Andersen, R, Antoine, JM et al. (2012) Application of the BRAFO tiered approach for benefit-risk assessment to case studies on dietary interventions. Food Chem Toxicol 50, Suppl 4, S710S723.
140. Dong, Y, Stallmann-Jorgensen, IS, Pollock, NK et al. (2010) A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 95, 45844591.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score